Whalegun
Home

Sarepta Therapeutics SRPT spent $430K on lobbying in Q3 2025 · Health Issues, Pharmacy and 2 more issues

Trade details

Type
Lobbying report
Amount
$430,000
Quarter
Q3 2025
Stock
Sarepta Therapeutics SRPT
Client
Sarepta Therapeutics
Reported
25/10/15

Up 65.4% from last quarter

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Sarepta Therapeutics's other lobbying reports

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $50K

    Reported 07/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $90K

    Reported 07/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $220K

    Reported 07/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $110K

    Reported 04/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $270K

    Reported 04/20